» Articles » PMID: 37091061

Co-infection of COVID-19 and Parasitic Diseases: A Systematic Review

Overview
Specialty Parasitology
Date 2023 Apr 24
PMID 37091061
Authors
Affiliations
Soon will be listed here.
Abstract

Co-infection of COVID-19 with other diseases increases the challenges related to its treatment management. COVID-19 co-infection with parasites is studied with low frequency. Here, we systematically reviewed the cases of parasitic disease co-infection with COVID-19. All articles on COVID-19 co-infected with parasites (protozoa, helminths, and ectoparasites), were screened through defined inclusion/exclusion criteria. Of 2190 records, 35 studies remained for data extraction. The majority of studies were about COVID-19 co-infected with malaria, followed by strongyloidiasis, amoebiasis, chagas, filariasis, giardiasis, leishmaniasis, lophomoniasis, myiasis, and toxoplasmosis. No or low manifestation differences were reported between the co-infected cases and naïve COVID-19 or naïve parasitic disease. Although there was a relatively low number of reports on parasitic diseases-COVID-19 co-infection, COVID-19 and some parasitic diseases have overlapping symptoms and also COVID-19 conditions and treatment regimens may cause some parasites re-emergence, relapse, or re-activation. Therefore, more attention should be paid to the on-time diagnosis of COVID-19 and the co-infected parasites.

Citing Articles

Inhibitory Effects of Secondary Metabolites and Their Synthetic Derivatives against SARS-CoV-2 M and NS2B/NS3 (ZIKV and DENV-2).

B Souza G, M Pontes C, de O Costa G, F de Sousa N, Tizziani T, E Pollo L ACS Omega. 2024; 9(44):44624-44638.

PMID: 39524678 PMC: 11541513. DOI: 10.1021/acsomega.4c07148.


Frequency of exposure to Toxoplasma gondii in COVID-19 patients: a systematic review and meta-analysis.

Leon-Figueroa D, Barboza J, Siddiq A, Aguirre-Milachay E, Quispe-Vicuna C, Sah R BMC Public Health. 2024; 24(1):2885.

PMID: 39427144 PMC: 11490129. DOI: 10.1186/s12889-024-20334-x.


Characteristics of SARS-CoV-2 and Opisthorchis viverrini coinfections: insights into immune responses and clinical outcomes.

Charoensuk L, Pinlaor S, Nimala B, Suttiprapa S, Prakobwong S Parasitol Res. 2024; 123(8):297.

PMID: 39120805 DOI: 10.1007/s00436-024-08317-8.


Emerging Microorganisms and Infectious Diseases: One Health Approach for Health Shared Vision.

Ristori M, Guarrasi V, Soda P, Petrosillo N, Gurrieri F, Longo U Genes (Basel). 2024; 15(7).

PMID: 39062687 PMC: 11275270. DOI: 10.3390/genes15070908.


Prevalence of sp. and other gastrointestinal pathogens among diarrheic COVID-19 patients in Italy.

Marangi M, Boughattas S, Valzano F, La Bella G, De Nittis R, Margaglione M New Microbes New Infect. 2024; 58:101228.

PMID: 38406386 PMC: 10884970. DOI: 10.1016/j.nmni.2024.101228.

References
1.
Kishore R, Dhakad S, Arif N, Dar L, Mirdha B, Aggarwal R . COVID-19: Possible Cause of Induction of Relapse of Plasmodium vivax Infection. Indian J Pediatr. 2020; 87(9):751-752. PMC: 7332844. DOI: 10.1007/s12098-020-03441-6. View

2.
Di Gennaro F, Marotta C, Locantore P, Pizzol D, Putoto G . Malaria and COVID-19: Common and Different Findings. Trop Med Infect Dis. 2020; 5(3). PMC: 7559940. DOI: 10.3390/tropicalmed5030141. View

3.
Jochum J, Kreuels B, Tannich E, Huber S, Schulze Zur Wiesch J, Schmiedel S . Malaria in the Time of COVID-19: Do Not Miss the Real Cause of Illness. Trop Med Infect Dis. 2021; 6(2). PMC: 8103267. DOI: 10.3390/tropicalmed6020040. View

4.
Mahase E . Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020; 368:m641. DOI: 10.1136/bmj.m641. View

5.
Alberca R, Yendo T, Ramos Y, Fernandes I, Oliveira L, Emidio Teixeira F . Case Report: COVID-19 and Chagas Disease in Two Coinfected Patients. Am J Trop Med Hyg. 2020; 103(6):2353-2356. PMC: 7695072. DOI: 10.4269/ajtmh.20-1185. View